INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
![Foto de INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)](/img/noimage.png)
![Foto de Hospital Universitario de Valme](/img/noimage_org.png)
Hospital Universitario de Valme
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valme (14)
2023
-
Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study
The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441
2022
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
Archivos de Bronconeumologia, Vol. 58, pp. 22-31
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1
-
Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
Neurologia, Vol. 36, Núm. 1, pp. 1-8
2019
-
Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386
2018
-
Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2457-2467
2016
-
Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients
American Journal of Gastroenterology, Vol. 111, Núm. 10, pp. 1456-1465
2014
-
IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
Journal of Clinical Virology
2013
-
IgM levels in plasma predict outcome in severe pandemic influenza
Journal of Clinical Virology, Vol. 58, Núm. 3, pp. 564-567
2012
-
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection
PLoS ONE, Vol. 7, Núm. 6